Stock Market - Business News, Market Data, Stock Analysis

Stocks Pullback Slightly in Reaction to October Jobs Report

Stocks took back some gains at the opening bell after the U.S. Labor Department's release of the latest employment data.

Berkshire is a Big American Express Backer: Chart of the Day

American Express isn't just the Chart of the Day -- it's also a Jim Cramer Action Alert Pick.

Cooper Tires Hopes to Keep Roll Going, Jim Cramer's New Pick

Even with the weekend ahead, Friday's earnings should be enough to keep investors engaged.

Markets Drift as Europe’s Economies Fail to Inspire, and Eyes are Fixed on U.S. Jobs.

European markets were mixed this morning, with one eye on today’s U.S. non-farm employment figures to help give direction.

Incoming JetBlue CEO on Falling Oil Prices, New JFK Terminal

TheStreet's Scott Gamm speaks with incoming JetBlue Airways CEO Robin Hayes on how falling oil prices impact the airline's bottom line and outlook.

Why Airfares Unlikely to Fall With Oil Prices

Real Money Previews

Jim Cramer on the Markets: Signs That Oil Will Stabilize

The price will bottom, maybe not far from here.

Why the Election Results Shouldn't Change the Way You Invest

Follow these CEOs into shares of their bargain stocks.

Jim Cramer on the Stock Market: Thinking the Unthinkable

Just how certain are you that oil has gone as low as it can go?

Mad Money Recap

'Mad Money' Lightning Round: Pull the Trigger on Baxter

Cramer likes Illumina but isn't a big fan of GEO Group or AK Steel Holdings.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Stocks With Big Insider Buying in November: NuStar, Huntsman and More

Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

5 Huge Stocks to Trade for Gains This Week: Berkshire Hathaway, Facebook and More

Here's this week's look at five big stocks to trade this week.

Hedge Funds Hate These 5 Stocks -- Should You?

Scouring fund managers' hate list is valuable for two important reasons: it includes names you should sell too, and it includes names that they're wrong about selling.

4 Tech and Telecom Stocks to Trade for Gains: China Telecom and More

As the big market indices test new all-time highs, focus on the strongest stocks within the sectors that are already outperforming.

Hedge Funds Love These 5 Consumer Stocks -- but Should You?

Hedge funds are buying consumer discretionary stocks with both hands. Does that mean you should too?

MainStreet

Wages Fail to Keep Up with Rising Housing Costs: Consumers Can't Afford to Own -- or Rent

For consumers willing and able to relocate, here are the cities with lower home prices and more affordable rentals.

Where Business Travelers Really Sleep: The Top Hotels for Road Warriors

Frugality reigns according to expense account data

Marijuana's Edible Evolution: Pot-Infused Product Makers Adjust As Rules Change

Manufacturers have until February to comply with new "emergency" regulations adopted after at least one death attributed to edible products

The Republicans Are In Charge of Congress: What's Next For Obamacare?

After a midterm sweep on Tuesday the Republicans are likely to turn their attention to Obamacare. What could that mean for your insurance?

Go Electronic on Gift Cards, Stop Giving Money Back to Retailers

About $43 billion worth of gift cards went unused from 2005 to 2012, benefiting only the retailers. There's a safer, better way to go.

TheStreet's Jim Cramer takes a look at Salix Pharmaceuticals, whose stock is plunging after the company announced a slew of bad news.

Rockwell Dialysis Therapy Wins Panel Support But Final FDA Approval? Not So Fast.

A deeply flawed FDA advisory panel voted to support Rockwell's iron replacement therapy for dialysis. FDA still must decide if the product is approvable.

Salix Shares Plummet on Disclosure of Accounting Scandal

Salix Pharmaceuticals has been rocked by an accounting scandal involving inventory levels of its key gastrointestinal drugs, forcing the company to cut financial forecasts for the rest of the year.

Beyond Wall St.

Taylor Swift Dominates, LabCorp Expands & Red Lobster Adds Surf

5 Huge Stocks to Trade for Gains This Week: Berkshire Hathaway, Facebook and More

Cannabis Gains Political Importance, Makes Its Way To The Ballot

Deal News

Proxy Advisory Firm, ISS, Has Updated its Quick Score 3.0 Product

Proxy advisory firm Institutional Shareholder Services Inc.’s latest product update could further bolster insurgency campaigns.

UCB Sells Generics Unit to Advent and Avista for $1.53 Billion

The transaction gives the buyout firms medicines including ADHD treatment Concerta.

Strategics Strong in 2014, Look to Continue Dealmaking Into 2015

Buoyed by favorable equity markets in 2013 going into 2014, strategics showed a strong deal appetite in the first half of 2014, winning a number of big name auctions.

TheStreetTV

Spin Space

Jim Cramer

Jim Cramer on the Markets: Signs That Oil Will Stabilize

The price will bottom, maybe not far from here.

Herb Greenberg

Herb Greenberg on the Stock Market: Herbalife's Reset Begins

After saying there was nothing wrong with its business model, Herbalife's strategy appears to be watering down the model in the face of increased regulatory scrutiny.

Stephanie Link

Surviving the Coming $80 Oil Winter - Recapping Q3 Energy Reports

Dan Dicker, energy contributor at thestreet.com, talks with Stephanie Link, co-portfolio director of Action Alerts about recent third quarter reports from oil companies.

Chris Ciaccia

How Tesla's 50% Growth Is At Risk From Production Issues

Tesla is on track to do something few car companies have ever done: grow 50% a year for the foreseeable future. But it needs to get its production levels straight.

Adam Feuerstein

Rockwell Dialysis Therapy Wins Panel Support But Final FDA Approval? Not So Fast.

A deeply flawed FDA advisory panel voted to support Rockwell's iron replacement therapy for dialysis. FDA still must decide if the product is approvable.

Dan Freed

Banks Are Seeing Big Gains From Managing Rich People's Money

Banks can't seem to get enough of the estimated $50-plus trillion wealth management business, but despite all the competition, revenues show no sign of slowing.

Ted Reed

Why Airfares Aren't Likely to Decline Despite Falling Fuel Prices

Despite falling fuel price, airlines are not reducing ticket prices nor are they rushing to open new routes -- something analysts fear.

Leon Lazaroff

Disney's 'Frozen' Will Become the Biggest Franchise Ever

Disney has shown it's preparing to ride 'Frozen' in products, theme parks and sequels that could last for decades.

DOW	17,539.83	-14.64	-0.08%
S&P 500	2,026.89	-4.32	-0.21%
NASDAQ	4,610.9840	-27.4850	-0.59%

SUBSCRIPTION SERVICES:

SUBSCRIPTION BUNDLES:

FREE:

Must Read